CGP 48369 is an angiotensin II receptor antagonist used in the study of antihypertensive therapies; it inhibits angiotensin II-induced contractions in vascular smooth muscle and lowers blood pressure in hypertensive rat models; it also enhances endothelium-dependent relaxation in response to acetylcholine in spontaneously hypertensive rats.